ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,475.09
      0.27%
      US Tech 100
      19,199.60
      -0.40%
      Dow Jones
      39,169.52
      0.13%
      Brent Oil
      86.825
      0.34%
      Bitcoin
      62,605.97
      -0.39%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. USOTC
      6. Aeolus Pharmaceuticals Inc (CE) (AOLS)

      7. Aeolus Pharmaceuticals Inc (CE) (AOLS) News

      AOLS

      Aeolus Pharmaceuticals (CE) (AOLS)

      Aeolus Pharmaceuticals Inc (CE)
      		Date:
      Sort by:
       Showing the most relevant articles for your search:USOTC:AOLS
      DateTimeSourceHeadlineSymbolCompany
      02/14/20145:00PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      02/14/20144:29PMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      02/13/20147:30AMMarketwiredAeolus Announces Process Improvements and Positive 18 Month Stability Results for AEOL 10150 in New FormulationUSOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      02/10/20147:30AMMarketwiredAeolus Announces Publication of Data Demonstrating Efficacy of AEOL 10150 in Animal Model of Lung Radiation Exposure; Models ...USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      01/23/201410:52AMMarketwiredAeolus Receives Orphan Drug Designation for AEOL 10150 From U.S. FDAUSOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      12/23/20138:00AMMarketwiredAeolus Announces Fiscal Year 2013 Financial ResultsUSOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      12/05/201311:14AMMarketwiredAeolus Files Application for New Patent on AEOL 10150USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      10/29/20138:00AMMarketwiredAeolus' AEOl 10150 Significantly Improves Survival and Protects Lungs in Mice Exposed to Lethal RadiationUSOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      09/17/20131:30PMMarketwiredBARDA Exercises $6.0MM in Additional Contract Funding for Development of AEOL-10150 as Treatment for Acute Radiation SyndromeUSOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      09/11/201312:20PMMarketwiredAeolus' AEOL 10150 Subject of $4.3 Million US Government Award for Protection Against Nerve Agents; Data Shows Drug Significa...USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      08/22/20136:01AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      08/21/20135:11PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      08/15/20134:03PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      08/15/20134:02PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      08/14/20135:34PMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      08/14/20134:30PMMarketwiredAeolus Announces Third Quarter Fiscal Year 2013 Financial ResultsUSOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      07/02/20138:00AMMarketwiredAeolus' AEOL 10150 Significantly Improves Survival From Nitrogen Mustard Exposure to Skin in AnimalsUSOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      06/26/20132:02PMMarketwiredAeolus' AEOL 10150 Significantly Improves Survival in Animals Exposed to Mustard GasUSOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      06/14/20132:04PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      06/14/20136:02AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      06/14/20136:02AMEdgar (US Regulatory)Notice of Effectiveness (effect)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      05/31/20135:27PMEdgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      05/23/20135:07PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      05/17/20132:19PMMarketwiredAeolus Strengthens Board of Directors With Oncology, Government Contracting and Financial Industry VeteransUSOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      05/17/201312:53PMEdgar (US Regulatory)Securities Registration Statement (s-1)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      05/17/201312:53PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      05/16/20135:25PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      05/15/20132:38PMMarketwiredAeolus Pharmaceuticals Announces Second Quarter Fiscal Year 2013 Financial ResultsUSOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      05/15/20132:19PMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      05/14/20134:12PMEdgar (US Regulatory)Amended Annual Report (10-k/a)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
       Showing the most relevant articles for your search:USOTC:AOLS